Arcturus Therapeutics Holdings Inc. (ARCT) short interest & options flow
NASDAQShort sellers have built a deeply entrenched position in ARCT ahead of its Q1 2026 results tonight — and the borrow market tells a quietly unusual story for a stock trading at $8.90. Short interest runs at 21.6% of the free float, one of the most heavily shorted readings in the biotech universe. The ORTEX short score has climbed to 81.9, ranking in just the 2nd percentile across…
- Market cap
- $294M
- Next earnings
- 10 Nov 2026
Key data as of 8 Nov 2026

ARCT news and analysis
RSSNo long-form analysis yet for ARCT. Pulse alerts and the live data picture are available on ORTEX.
Open ARCT on ORTEX →Want the live picture for ARCT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARCT — free to start on ORTEX.
Sign up for free →Open ARCT on ORTEX